Skip to main content
Log in

Cytokine Responses to Specific Immunotherapy in House Dust Mite-Induced Allergic Rhinitis Patients

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Allergen-specific immunotherapy is the only immunomodulatory treatment that may alter the natural course of allergic disease. However, cytokine responses accompanying sublingual immunotherapy (SLIT) responder phenotypes have not been fully understood. Herein, we examined the level of crucial plasma cytokines during SLIT and evaluated whether their changes correlated to symptom scores. We observed that the levels of interleukin (IL)-17 and complement components C3a and C5a as well as IL-4 at year 3 of SLIT were significantly decreased than those at baseline. In contrast, there was no significant difference in the levels of IL-5, IL-13, and interferon (IFN)-γ. Notably, a significant positive correlation was found between the levels of IL-17 and the symptom scores at year 3. These results suggest that IL-17 could be considered a potential biomarker for the therapeutic effect of SLIT in allergic rhinitis caused by house dust mite.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

REFERENCES

  1. Compalati, E., G. Passalacqua, M. Bonini, and G.W. Canonica. 2009. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy 64: 1570–1579.

    Article  CAS  PubMed  Google Scholar 

  2. Radulovic, S., D. Wilson, M. Calderon, and S. Durham. 2011. Systematic reviews of sublingual immunotherapy (SLIT). Allergy 66: 740–752.

    Article  CAS  PubMed  Google Scholar 

  3. Walker, S.M., S.R. Durham, S.J. Till, G. Roberts, C.J. Corrigan, S.C. Leech, et al. 2011. Immunotherapy for allergic rhinitis. Clinical and Experimental Allergy 41: 1177–1200.

    Article  CAS  PubMed  Google Scholar 

  4. Wilson, D.R., M.T. Lima, and S.R. Durham. 2005. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 60: 4–12.

    Article  CAS  PubMed  Google Scholar 

  5. Penagos, M., E. Compalati, F. Tarantini, R. Baena-Cagnani, J. Huerta, G. Passalacqua, et al. 2006. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Annals of Allergy, Asthma & Immunology 97: 141–148.

    Article  CAS  Google Scholar 

  6. Mortemousque, B., F. Bertel, J. De Casamayor, P. Verin, and J. Colin. 2003. House-dust mite sublingual-swallow immunotherapy in perennial conjunctivitis: a double-blind, placebo-controlled study. Clinical and Experimental Allergy 33: 464–469.

    Article  CAS  PubMed  Google Scholar 

  7. Passalacqua, G., M. Pasquali, R. Ariano, C. Lombardi, A. Giardini, I. Baiardini, et al. 2006. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites. Allergy 61: 849–854.

    Article  CAS  PubMed  Google Scholar 

  8. de Blay, F., C. Barnig, G. Kanny, A. Purohit, F. Leynadier, J.M. Tunon de Lara, et al. 2007. Sublingual-swallow immunotherapy with standardized 3-grass pollen extract: a double-blind, placebo-controlled study. Annals of Allergy, Asthma & Immunology 99: 453–461.

    Article  Google Scholar 

  9. Bohle, B., T. Kinaciyan, M. Gerstmayr, A. Radakovics, B. Jahn-Schmid, and C. Ebner. 2007. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. Journal of Allergy and Clinical Immunology 120: 707–713.

    Article  CAS  PubMed  Google Scholar 

  10. Guez, S., C. Vatrinet, R. Fadel, and C. Andre. 2000. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study. Allergy 55: 369–375.

    Article  CAS  PubMed  Google Scholar 

  11. Canonica, G.W., C.E. Baena-Cagnani, J. Bousquet, P.J. Bousquet, R.F. Lockey, H.J. Malling, et al. 2007. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 62: 317–324.

    Article  CAS  PubMed  Google Scholar 

  12. Ciprandi, G., M. De Amici, G. Murdaca, D. Fenoglio, F. Ricciardolo, G. Marseglia, et al. 2009. Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. Allergy 64: 1375–1378.

    Article  CAS  PubMed  Google Scholar 

  13. Ciprandi, G., D. Fenoglio, M. De Amici, S. Quaglini, S. Negrini, and G. Filaci. 2008. Serum IL-17 levels in patients with allergic rhinitis. Journal of Allergy and Clinical Immunology 122(650–651), e652.

    Google Scholar 

  14. Liu, T., C.H. Song, A.M. Liu, C. Xie, F. Zhao, X. Chen, et al. 2011. Forkhead box P3+ T cells express interleukin-17 in nasal mucosa of patients with both allergic rhinitis and polyposis. Clinical and Experimental Immunology 163: 59–64.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Lajoie, S., I.P. Lewkowich, Y. Suzuki, J.R. Clark, A.A. Sproles, K. Dienger, et al. 2010. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nature Immunology 11: 928–935.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Grailer, J.J., M. Bosmann, and P.A. Ward. 2012. Regulatory effects of C5a on IL-17A, IL-17F, and IL-23. Frontiers in Immunology 3: 387.

    PubMed Central  PubMed  Google Scholar 

  17. Andersson, M., L. Michel, J.B. Llull, and U. Pipkorn. 1994. Complement activation on the nasal mucosal surface—a feature of the immediate allergic reaction in the nose. Allergy 49: 242–245.

    Article  CAS  PubMed  Google Scholar 

  18. Hidvegi, T., B. Schmidt, L. Varga, M. Dervaderics, A. Lantos, Z. Gonczi, et al. 1995. In vitro complement activation by ragweed allergen extract in the sera of ragweed allergic and non-allergic persons. Immunology Letters 48: 65–71.

    Article  CAS  PubMed  Google Scholar 

  19. Zhang, X., and J. Kohl. 2010. A complex role for complement in allergic asthma. Expert Review of Clinical Immunology 6: 269–277.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Klos, A., A.J. Tenner, K.O. Johswich, R.R. Ager, E.S. Reis, and J. Kohl. 2009. The role of the anaphylatoxins in health and disease. Molecular Immunology 46: 2753–2766.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Mizutani, N., H. Goshima, T. Nabe, and S. Yoshino. 2012. Complement C3a-induced IL-17 plays a critical role in an IgE-mediated late-phase asthmatic response and airway hyperresponsiveness via neutrophilic inflammation in mice. Journal of Immunology 188: 5694–5705.

    Article  CAS  Google Scholar 

  22. Kohl, J., and M. Wills-Karp. 2007. A dual role for complement in allergic asthma. Current Opinion in Pharmacology 7: 283–289.

    Article  PubMed  Google Scholar 

  23. Engelke, C., A.V. Wiese, I. Schmudde, F. Ender, H.A. Strover, T. Vollbrandt, et al. 2014. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma. Journal of Immunology 193: 5387–5401.

    Article  CAS  Google Scholar 

  24. Zhang, X., I. Schmudde, Y. Laumonnier, M.K. Pandey, J.R. Clark, P. Konig, et al. 2010. A critical role for C5L2 in the pathogenesis of experimental allergic asthma. Journal of Immunology 185: 6741–6752.

    Article  CAS  Google Scholar 

  25. Locksley, R.M. 2008. The roaring twenties. Immunity 28: 437–439.

    Article  CAS  PubMed  Google Scholar 

  26. Cosmi, L., L. Maggi, V. Santarlasci, M. Capone, E. Cardilicchia, F. Frosali, et al. 2010. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. Journal of Allergy and Clinical Immunology 125(222–230): e221–224.

    Google Scholar 

  27. Wang, Y.H., K.S. Voo, B. Liu, C.Y. Chen, B. Uygungil, W. Spoede, et al. 2010. A novel subset of CD4(+) T (H) 2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. Journal of Experimental Medicine 207: 2479–2491.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Irvin, C., I. Zafar, J. Good, D. Rollins, C. Christianson, M.M. Gorska, et al. 2014. Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma. Journal of Allergy and Clinical Immunology 134(1175–1186), e1177.

    Google Scholar 

  29. Kim, H.Y., H.J. Lee, Y.J. Chang, M. Pichavant, S.A. Shore, K.A. Fitzgerald, et al. 2014. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nature Medicine 20: 54–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Ramesh, R., L. Kozhaya, K. McKevitt, I.M. Djuretic, T.J. Carlson, M.A. Quintero, et al. 2014. Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. Journal of Experimental Medicine 211: 89–104.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Funding

This work was funded by Developing Funds for Medicine (JW-2324).

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mingqiang He.

Additional information

Hong Li and Enxiu Xu contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, H., Xu, E. & He, M. Cytokine Responses to Specific Immunotherapy in House Dust Mite-Induced Allergic Rhinitis Patients. Inflammation 38, 2216–2223 (2015). https://doi.org/10.1007/s10753-015-0204-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-015-0204-3

KEY WORDS

Navigation